Long‐term outcomes of biologic therapy for the treatment of prepouch ileitis: A multi‐centre multi‐national retrospective study
First-line biologic treatment for PPI is associated with high rates of treatment discontinuation. A significant proportion of PPI patients initially treated with biologics develop pouch failure.
Authors
- Eduard Koifman (ORCID: https://orcid.org/0009-0008-5423-3121)
- Heather E. Johnson (ORCID: https://orcid.org/0000-0001-5392-7676)
- Simon D. McLaughlin (ORCID: https://orcid.org/0000-0003-4390-1485)
- Maya Fischman (ORCID: https://orcid.org/0009-0006-8191-055X)
- Itai Ghersin (ORCID: https://orcid.org/0000-0003-0714-5686)
- Matteo Rottoli (ORCID: https://orcid.org/0000-0003-0278-4139)
- Janindra Warusavitarne (ORCID: https://orcid.org/0000-0002-7950-2833)
- Orestis Argyriou
- Ailsa L Hart (ORCID: https://orcid.org/0000-0002-7141-6076)
- Valerio Celentano (ORCID: https://orcid.org/0000-0002-3562-9082)
- Giacomo Calini (ORCID: https://orcid.org/0000-0002-7460-9578)
- Jonathan Segal (ORCID: https://orcid.org/0000-0002-9668-0316)
- Kapil Sahnan (ORCID: https://orcid.org/0000-0003-3885-5752)
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Hebrew University of Jerusalem (IL)
- Royal Bournemouth Hospital (GB)
- Rambam Health Care Campus (IL)
- Azienda USL di Bologna (IT)
- Chelsea and Westminster Hospital (GB)
- St Mark's Hospital (GB)
- Imperial College London (GB)
- University of Bologna (IT)
Publication Details
- Journal
- Colorectal Disease
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1111/codi.70252
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63